Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +38.90%
#2 Siren Siren +30.85%
#3 Purr Purr +26.84%
#4 Prom Prom +18.94%
#5 Pendle Pendle +17.96%
#6 DigiByte DigiByte +17.66%
#7 OriginTrail OriginTrail +17.10%
#8 UnifAI Network UnifAI Network +15.42%
#9 Plasma Plasma +13.17%
#10 Unit Plasma Unit Plasma +13.17%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Rank in Stocks #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Share Price
$3.01
Last synced: 2024-04-12
Market Cap
$104.64M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Cyteir Therapeutics, Inc. (CYT)

Category

Healthcare
Stock price history for Cyteir Therapeutics, Inc. (CYT)
Highest end of day price: $3.01 on 2024-04-01

Lowest end of day price: $18.73 on 2021-06-01
Stock price history of Cyteir Therapeutics, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH